RTX Corp: Form 10-Q for the period ended Mar 31, 2022
Filed with the SEC on Apr 26, 2022 and accepted by EDGAR at Apr 26, 2022, 16:18 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-01-01 to 2022-03-31 | $15.72bn | us-gaap:Revenues |
| Research and development | 3 months2022-01-01 to 2022-03-31 | $635.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-01-01 to 2022-03-31 | $1.47bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-01-01 to 2022-03-31 | $1.08bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-01-01 to 2022-03-31 | $318.0m | us-gaap:InterestExpense |
| Income tax | 3 months2022-01-01 to 2022-03-31 | $116.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-01-01 to 2022-03-31 | $1.08bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-01-01 to 2022-03-31 | $0.72 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-01-01 to 2022-03-31 | $0.73 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-01-01 to 2022-03-31 | 1,497,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Dividends paid | 3 months2022-01-01 to 2022-03-31 | $745.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2022-01-01 to 2022-03-31 | $743.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-03-31 | $6.04bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-03-31 | $40.74bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-03-31 | $159.37bn | us-gaap:Assets |
| Current liabilities | At period end2022-03-31 | $35.06bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-03-31 | $85.34bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2022-03-31 | $140.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2022-03-31 | $72.46bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2022-03-31 | 1,487,215,106 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000101829-22-000018. Last ingested by Listed: Nov 3, 2026, 21:25 ET. Listed shows no prices and gives no investment advice.